AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

January 14, 2026

BMJ Investigation Shines Light on Semaglutide U.K. Marketing

December 18, 2023

FDA expert panel backs Eli Lilly’s Alzheimer’s drug donanemab

June 13, 2024

Must Read

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

July 22, 2026

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

July 22, 2026

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

July 20, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

The Return of M&A as a Growth Strategy in Biopharma

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

Why Traditional Pharma Marketing Models Are Being Rewritten

Tag: FDA Approval

FDA Approves Zycubo as First U.S. Treatment for Pediatric Menkes Disease

Editor Picks

AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

BMJ Investigation Shines Light on Semaglutide U.K. Marketing

FDA expert panel backs Eli Lilly’s Alzheimer’s drug donanemab

Must Read

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

Hot Topics

About Us

Follow Us